Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 109INDUSTRY 25NIH 10NETWORK 9OTHER_GOV 6UNKNOWN 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 3Nasopharyngeal Carcinoma 3Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Nasopharyngeal Neoplasms 1Locally Advanced Malignant Neoplasm 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Paclitaxel 8nedaplatin 3TP protocol 3nimotuzumab 2S 1 (combination) 2Radiation 2Esophagectomy 2Cisplatin 2pegylated granulocyte colony-stimulating factor 1Radiotherapy, Adjuvant 1Platinum 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
UNKNOWN × Esophageal Neoplasms × Cisplatin × Clear all
NCT02279134 2020-04-03

Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

ChineseAMS

Phase 2/3 Unknown
360 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02446574 2017-10-24

Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma

ChineseAMS

Phase 1/2 Completed
33 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡